COMBINATION OF PI3KINASE INHIBITORS AND AURORA KINASE INHIBITORS

• 1. 含有PDE4抑制剂和PI3δ或双重PI3δ-γ激酶抑制剂的药物组合物 [P] . 中国专利： CN104870017B . 2020.08.14
• 2. 含有PDE4抑制剂和PI3 δ或双重PI3 δ-γ激酶抑制剂的药物组合物 [P] . 中国专利： CN111904962A . 2020-11-10
• 3. COMBINATION OF PI3KINASE INHIBITORS AND SPLEEN TYROSINE KINASE INHIBITORS [P] . 世界知识产权组织专利： WO2017015440A2 . 2017-01-26

  机译： PI3激酶抑制剂和脾酪氨酸激酶抑制剂的组合

• 4. SUBSTITUTED QUINAZOLINE DERIVATIVES AS INHIBITORS SUBSTITUTED QUINAZOLINE DERIVATIVES AS INHIBITORS OF AURORA KINASES OF AURORA KINASES [P] . CA2471577A1 . 2003-07-10

  机译： 取代的喹唑啉衍生物作为抑制剂取代的喹唑啉衍生物作为抑制剂极光激酶的抑制剂

• 5. COMBINATION OF MEK INHIBITORS AND SELECTIVE INHIBITORS OF AURORA A KINASE [P] . EP2713727B1 . 2021-03-31

  机译： 梅克抑制剂的组合和极光激酶的选择性抑制剂

• 1. Effects of tyrosine kinase inhibitor E7080 and eNOS inhibitor L-NIO on colorectal cancer alone and in combination [J] . Ahmet Altun, Tijen Kaya Temiz, Ezgi Balc(i), 中国癌症研究（英文版） . 2013,第005期
• 2. Activity of histone deacetylase inhibitors and an Aurora kinase inhibitor in BCR-ABL-expressing leukemia cells: Combination of HDAC and Aurora inhibitors in BCR-ABL-expressing cells [J] . Seiichi Okabe, Tetsuzo Tauchi, Yuko Tanaka, Cancer Cell International . 2013,第1期
• 3. Activity of histone deacetylase inhibitors and an Aurora kinase inhibitor in BCR-ABL-expressing leukemia cells: Combination of HDAC and Aurora inhibitors in BCR-ABL-expressing cells [J] . Seiichi Okabe, Tetsuzo Tauchi, Yuko Tanaka, Cancer Cell International . 2013,第1期
• 4. Pictilisib PI3Kinase inhibitor (a phosphatidylinositol 3-kinase [PI3K] inhibitor) plus paclitaxel for the treatment of hormone receptor-positive, HER2-negative, locally recurrent, or metastatic breast cancer: interim analysis of the multicentre, placebo-controlled, phase II randomised PEGGY study [J] . Vuylsteke P., Huizing M., Petrakova K., Annals of oncology: official journal of the European Society for Medical Oncology . 2016,第11期
• 5. Assessing non-mitotic pathways of an Aurora kinase inhibitor using chemical labeling and label-free MS approaches [C] . Matthew J. McKay, Judith Nicholson, Mark P. Molloy American Society for Mass Spectrometry Conference on Mass Spectrometry and Allied Topics . 2013
• 6. Biochemical Context Drives Inhibitor Selectivity in Aurora A Kinase [D] . Lake, Eric William. 2021
• 7. Activity of histone deacetylase inhibitors and an Aurora kinase inhibitor in BCR-ABL-expressing leukemia cells: Combination of HDAC and Aurora inhibitors in BCR-ABL-expressing cells [O] . Seiichi Okabe, Tetsuzo Tauchi, Yuko Tanaka, 2013
• 8. Activity of histone deacetylase inhibitors and an Aurora kinase inhibitor in BCR-ABL-expressing leukemia cells: Combination of HDAC and Aurora inhibitors in BCR-ABL-expressing cells [O] . Seiichi Okabe, Tetsuzo Tauchi, Yuko Tanaka, 2013

• 1. Evaluation of the Aurora Kinase Inhibitor, ZM447439, in Canine Malignant Lymphoid Cells iin Vitro/i [J] . Keijiro Shiomitsu ,Xueqing Xia ,Kyle Waite . 兽医学（英文） . 2013,第1期
• 2. Jadomycin B, an Aurora-B kinase inhibitor discovered through virtual screening [J] . Da Huafu ,Jing Zhang ,Jian Tingzheng . 癌症进展 . 2008,第003期
• 3. MK615 inhibits pancreatic cancer cell growth by dual inhibition of Aurora A and B kinases [J] . Toshie Okada ,Tokihiko Sawada ,Tatsushi Osawa . 世界胃肠病学杂志：英文版 . 2008,第9期
• 4. Overexpression of Aurora-A kinase promotes tumor cell proliferation and inhibits apoptosis in esophageal squamous cell carcinoma cell line [J] . Xiao Xia Wang ,Rong Liu ,Shun Qian Jin . 细胞研究：英文版 . 2006,第4期
• 5. 酪氨酸激酶抑制剂基础上异基因造血干细胞移植优于酪氨酸激酶抑制剂单药治疗慢性髓性白血病急变期患者 [C] . 江浩 ,许兰平 ,刘代红 . 中华医学会第十二次全国血液学学术会议 . 2012
• 6. 计算机辅助磺胺类药物、β-内酰胺酶抑制剂、极光激酶抑制剂类似物的设计 [A] . 王芸 . 2009